The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse
Pfizer (United States) · Eli Lilly (United States) · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,707
total citations
- FWCI
- 14.87
- Percentile
- 100%
- References
- 26
Citations per year
Authors
4- SGS.S. GlassonCorresponding
Pfizer (United States)
- MCM.G. ChambersCorresponding
Eli Lilly (United States)
- WBW. B. Van Den BergCorresponding
Radboud University Nijmegen, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences
- CBChristopher B. LittleCorresponding
The University of Sydney, Royal North Shore Hospital
Topics & keywords
Topics
Keywords
- Scoring system
- Osteoarthritis
- Femur
- Cartilage
- Medicine
- Histopathology
- Tibia
- Cartilage damage
No related works found for this paper.